Unlocking the Mysteries of Rare Disease Drug Development: A Beginner's Guide for Clinical Pharmacologists
Clinical and Translational Science · 2025
DOI: 10.1111/cts.70215 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Translational Science, 2025. Verfasst von Mariam A Ahmed und 9 weiteren Autor:innen. Beteiligte Einrichtung: Takeda Pharmaceuticals, Cambridge, MA, USA. Hauptthemen laut MEDLINE: Rare Diseases, Drug Development, Orphan Drug Production, Pharmacology, Clinical. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Clinical pharmacologists face unique challenges when developing drugs for rare diseases. These conditions are characterized by small patient populations, diverse disease progression patterns, and a limited understanding of underlying pathophysiology. This tutorial serves as a comprehensive guide, offering practical insights and strategies to navigate its complexities. In this tutorial, we outline global regulatory incentives and resources available to support rare disease research, describe some considerations for designing a clinical development plan for rare diseases, and we highlight the role of biomarkers, real‐world data, and modeling and simulations to navigate rare disease challenges. By leveraging these tools and understanding regulatory pathways, clinical pharmacologists can significantly contribute to advancing therapeutic options for rare diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Takeda Pharmaceuticals, Cambridge, MA, USA.
- Boehringer Ingelheim, Ridgefield, CT, USA.
- Aridhia Bioinformatics, Glasgow, UK.
- Novartis, Cambridge, MA, USA.
- US Food and Drug Administration, Silver Spring, Maryland, USA.
- Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
ORCID-Profile: Mariam A Ahmed, Jeffrey S Barrett, Yuen Yi Hon, Salwa Albusaysi, Maria Burian, Noha Rayad
Zitieren
APA
Ahmed, M. A., AbuAsal, B., Barrett, J. S., Azer, K., Hon, Y. Y., Albusaysi, S., Shang, E., Wang, M., Burian, M., & Rayad, N. (2025). Unlocking the Mysteries of Rare Disease Drug Development: A Beginner's Guide for Clinical Pharmacologists. Clinical and Translational Science. https://doi.org/10.1111/cts.70215
Vancouver
Ahmed MA, AbuAsal B, Barrett JS, Azer K, Hon YY, Albusaysi S, et al. Unlocking the Mysteries of Rare Disease Drug Development: A Beginner's Guide for Clinical Pharmacologists. Clinical and Translational Science. 2025. doi:10.1111/cts.70215
BibTeX
@article{Ahmed2025,
author = {Ahmed, Mariam A and AbuAsal, Bilal and Barrett, Jeffrey S and Azer, Karim and Hon, Yuen Yi and Albusaysi, Salwa and Shang, Elizabeth and Wang, Meng and Burian, Maria and Rayad, Noha},
title = {Unlocking the Mysteries of Rare Disease Drug Development: A Beginner's Guide for Clinical Pharmacologists},
journal = {Clinical and Translational Science},
year = {2025},
doi = {10.1111/cts.70215}
}
EUVIMED